Atlas Trials

8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia

Clinical trial NCT00739999 · COMPLETED

Trial details

NCT number
NCT00739999
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric Heterozygous Hypercholesterolemia
Start date
2008-12-01
Primary completion
2009-05-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.